Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 7Terminated 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 3Head & Neck 2Gynecologic 2Tumor-Agnostic 1Other hematologic neoplasm 1Myeloid 1Gastrointestinal 1

Conditions

Advanced Solid Tumours 2Advanced Solid Tumors 1

Interventions

pembrolizumab 26Cisplatin 15Pemetrexed 14Paclitaxel 14Carboplatin 14Nivolumab 10Cyclophosphamide 10Docetaxel 8atezolizumab 7Injections 7Melphalan 6tislelizumab 5olaparib 5Gemcitabine 5Filgrastim 5durvalumab 4aldesleukin 4Leucovorin 4Irinotecan 4Granulocyte Colony-Stimulating Factor 4Etoposide 4Bevacizumab 4tocilizumab 3spartalizumab 3liposomal doxorubicin 3ixabepilone 3fludarabine 3epacadostat 3defactinib 3adavosertib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × adavosertib × Other solid neoplasm × Clear all
NCT04959266 2022-09-16

A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

AstraZeneca

Phase 1 Terminated
5 enrolled
Other solid neoplasm

Advanced Solid Tumours

NCT05008913 2022-09-06

ADME

AstraZeneca

Phase 1 Terminated
2 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT04949425 2022-09-02

A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours

AstraZeneca

Phase 1 Terminated
3 enrolled
Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡